We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Treatment of Relapsed or Refractory Acute Myeloblastic Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01435343
Recruitment Status : Completed
First Posted : September 16, 2011
Last Update Posted : April 25, 2017
Information provided by (Responsible Party):
PETHEMA Foundation